Figures & data
Figure 2. Trends in number of cases and incidence of pneumococcal meningitis in France from 2001 to 2012.
![Figure 2. Trends in number of cases and incidence of pneumococcal meningitis in France from 2001 to 2012.](/cms/asset/c29aebfe-9f81-47dd-b394-899d7df93376/khvi_a_1116654_f0002_c.gif)
Figure 3. Trends in number of cases and incidence of non-meningitis invasive pneumococcal disease (Epibac network) from 2001 to 2012.
![Figure 3. Trends in number of cases and incidence of non-meningitis invasive pneumococcal disease (Epibac network) from 2001 to 2012.](/cms/asset/8a67cfa0-e465-48b4-a1a6-abae5fb6dd2a/khvi_a_1116654_f0003_c.gif)
Figure 4. Distribution of pneumococcal diseases and underlying condition by serotype from 2011 to 2014 (GPIP/ACTIV network).
![Figure 4. Distribution of pneumococcal diseases and underlying condition by serotype from 2011 to 2014 (GPIP/ACTIV network).](/cms/asset/f27cfe2a-071a-42c4-8d19-2e5740369367/khvi_a_1116654_f0004_c.gif)
Figure 5. Trends in proportion of community-acquired pneumonia (CAP) (bacteremic and non bacteremic pneumonia) from 2009 to 2012.
![Figure 5. Trends in proportion of community-acquired pneumonia (CAP) (bacteremic and non bacteremic pneumonia) from 2009 to 2012.](/cms/asset/696d7624-c2b9-4154-b8e4-21f59c8281c6/khvi_a_1116654_f0005_c.gif)